Apatinib Mesylate
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Apatinib Mesylate, covering 2017-02-17 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. [Phase 1, Phase 2]